CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Sayeda Yasmin‐Karim

OPENALEX: A5078050353↗

Affiliations

Organizations

Brigham and Women's Hospitalauthorship · US Dana-Farber Brigham Cancer Centerauthorship · US Dana-Farber Cancer Instituteauthorship · US Harvard Universityauthorship · US

Public evidence

3 connected articles

From farm to bedside: Potential of medical cannabis in global health.2025 · Europe PMC Corrigendum: Flavonoid Derivative of <i>Cannabis</i> Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer.2020 · PubMed Central Open Access Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer.2019 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Sayeda Yasmin‐Karim - Medical Cannabis Research Engine